Ahead of a rights issue, PMDS publishes it's preliminary results for Q2 2024, revealing a remarkable 30.9% increase in revenue from the previous year. With the acquisition of a remote patient monitoring company in the US, PMDS has successfully accelerated its market entry into America, significantly expanding its impact on patients #globally. “We are achieving our priorities for this year, and the forthcoming rights issue is an important prerequisite to support an extended growth period for PMDS. As we continue to grow, our focus remains on expanding our market presence in the US, the UK, and Germany" says founder CEO Myles Murray #medtech #digitalhealthcare #remotepatientmonitoring Enterprise Ireland #MakingEveryBreathCount
PMD Solutions releases preliminary P&L results ahead of Q2 Interim Report Today, Myles Murray, CEO of PMD Solutions announced that consolidated net sales increased by 30.9% in Q2, which is in line with expectations in the newly significantly increased financial target for 2024 - 2026. Operating expenses increased more than we at LSIF expected due to one time costs related to the restructuring of the acquired US operation. For LSIF the most important message was, that PMD Solutions maintains, that the company will be cash flow positive by the end of 2024. LSIF is a lead guarantor in the upcoming rights issue Aug. 19th to Sept. 2nd. With the revised financial goals in June and todays press release, LSIF remain confident in PMDS and look forward to becoming a major shareholder. #lsif #lifescienceinvestfund #RespiraSense #MakingEveryBreathCount #virtualwards